[go: up one dir, main page]

HK1155160B - 含甲基吗啉取代的吡啶[2，3-d]嘧啶的组合物以及制备该化合物的方法 - Google Patents

含甲基吗啉取代的吡啶[2，3-d]嘧啶的组合物以及制备该化合物的方法 Download PDF

Info

Publication number
HK1155160B
HK1155160B HK11109366.4A HK11109366A HK1155160B HK 1155160 B HK1155160 B HK 1155160B HK 11109366 A HK11109366 A HK 11109366A HK 1155160 B HK1155160 B HK 1155160B
Authority
HK
Hong Kong
Prior art keywords
alkyl
bis
amino
alkoxy
group
Prior art date
Application number
HK11109366.4A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1155160A1 (zh
Inventor
Helen Blade
Gwydion Huw Churchill
Angela Charlotte Currie
Benjamin Charles Dobson
Peter Samuel Hynes
Martin Neal Kenworthy
Lyn Powell
Steven Anthony Raw
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority claimed from PCT/GB2009/050695 external-priority patent/WO2009153597A2/en
Publication of HK1155160A1 publication Critical patent/HK1155160A1/zh
Publication of HK1155160B publication Critical patent/HK1155160B/zh

Links

HK11109366.4A 2008-06-20 2009-06-18 含甲基吗啉取代的吡啶[2，3-d]嘧啶的组合物以及制备该化合物的方法 HK1155160B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US74188 1979-09-10
US152350 1993-11-12
US7418808P 2008-06-20 2008-06-20
US15235009P 2009-02-13 2009-02-13
PCT/GB2009/050695 WO2009153597A2 (en) 2008-06-20 2009-06-18 Composition and process - 356

Publications (2)

Publication Number Publication Date
HK1155160A1 HK1155160A1 (zh) 2012-05-11
HK1155160B true HK1155160B (zh) 2013-07-26

Family

ID=

Similar Documents

Publication Publication Date Title
EP2303875B1 (en) Compositions with and process for methylmorpholin-subsituted pyrido[2,3-d]pyrimidines
TWI736550B (zh) 製備ｐａｒｐ抑制劑、結晶形式的方法及其用途
TWI516263B (zh) 經取代之５－氟－１ｈ－吡唑并吡啶類及其用途
CN104955823B (zh) 羧基取代的咪唑并[1,2‑a]吡啶甲酰胺及其作为可溶性鸟苷酸环化酶的刺激物的用途
JP5940062B2 (ja) 環縮合４−アミノピリミジンおよび可溶性グアニル酸シクラーゼの刺激剤としてのその使用
TWI845819B (zh) 用作激酶抑制劑的化合物及其應用
TW201716416A (zh) 作為ｊａｋ激酶抑制劑之萘啶化合物
KR20110130463A (ko) Ｒａｆ 키나제의 억제를 위한 피롤로［２,３-ｂ］피리딘 유도체
KR20110125670A (ko) Ｒａｆ 키나제의 억제를 위한 피롤로［２,３-ｂ］피리딘 유도체
TW201702241A (zh) B-raf 激酶抑制劑的馬來酸鹽、其結晶形式、製備方法及用途
CA2816639A1 (en) Benzyl-substituted carbamates and use thereof
CA2651556A1 (en) 3-tetrazolylindazoles and 3-tetrazolylpyrazolopyridines and their use
CA2932482A1 (en) Aryl- and hetaryl-substituted imidazo[1,2-a]pyridine-3-carboxamides and use thereof
TW202530210A (zh) Ｋｒａｓ抑制劑之晶型
CA2943005A1 (en) Cyano-substituted imidazo[1,2-a]pyridinecarboxamides and their use
CA2939793A1 (en) 3-(pyrimidine-2-yl)imidazo[1,2-a]pyridines
TWI875727B (zh) 有機化合物之結晶形及鹽型及其醫藥組合物
JP2022512536A (ja) 癌を治療するために有用なＥｒｂＢ調節剤としての４－置換ピロロ［２，３－ｂ］ピリジン
JP2024545235A (ja) 複素芳香族化合物、その製造方法及び使用
WO2018157730A1 (zh) 脲取代的芳环连二噁烷并喹唑啉与连二噁烷并喹啉类化合物及其制备方法与应用
HK1155160B (zh) 含甲基吗啉取代的吡啶[2，3-d]嘧啶的组合物以及制备该化合物的方法
TW201728329A (zh) 一種含有吡啶并嘧啶類衍生物或其可藥用鹽的醫藥組成物
TW201136930A (en) Bridged morpholino substituted purines
US20250136579A1 (en) Salts and free bases of bifunctional compound and polymorph forms thereof
TW202342041A (zh) 一種藥物組合物及所含活性成分化合物的製備方法